PFBT
CORT icon

Parkside Financial Bank & Trust’s Corcept Therapeutics CORT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.78K Buy
69
+16
+30% +$598 ﹤0.01% 2004
2025
Q4 		$1.84K Buy
53
+12
+29% +$943 ﹤0.01% 2130
2025
Q3 		$3.41K Sell
41
-52
-56% -$3.76K ﹤0.01% 1842
2025
Q2 		$6.83K Buy
93
+31
+50% +$2.25K ﹤0.01% 1610
2025
Q1 		$7.08K Buy
62
+40
+182% +$2.44K ﹤0.01% 1527
2024
Q4 		$1.11K Hold
22
– – ﹤0.01% 1719
2024
Q3 		$1.02K Hold
22
– – ﹤0.01% 1704
2024
Q2 		$715 Hold
22
– – ﹤0.01% 1707
2024
Q1 		$555 Sell
22
-2
-8% -$47 ﹤0.01% 1730
2023
Q4 		$780 Sell
24
-332
-93% -$9.12K ﹤0.01% 1664
2023
Q3 		$9.7K Hold
356
– – ﹤0.01% 1132
2023
Q2 		$7.92K Hold
356
– – ﹤0.01% 1201
2023
Q1 		$7.71K Buy
356
+33
+10% +$723 ﹤0.01% 1195
2022
Q4 		$6.56K Hold
323
– – ﹤0.01% 1211
2022
Q3 		$8K Hold
323
– – ﹤0.01% 1049
2022
Q2 		$8K Buy
323
+24
+8% +$523 ﹤0.01% 1059
2022
Q1 		$7K Sell
299
-108
-27% -$2.3K ﹤0.01% 1142
2021
Q4 		$8K Buy
407
+46
+13% +$933 ﹤0.01% 1094
2021
Q3 		$7K Buy
361
+4
+1% +$84 ﹤0.01% 1072
2021
Q2 		$8K Buy
357
+26
+8% +$579 ﹤0.01% 1029
2021
Q1 		$8K Hold
331
– – ﹤0.01% 1002
2020
Q4 		$9K Buy
331
+215
+185% +$4.53K ﹤0.01% 900
2020
Q3 		$2K Buy
116
+5
+5% +$80 ﹤0.01% 1139
2020
Q2 		$2K Hold
111
– – ﹤0.01% 1145
2020
Q1 		$1K Sell
111
-25
-18% -$309 ﹤0.01% 1230
2019
Q4 		$2K Hold
136
– – ﹤0.01% 1152
2019
Q3 		$2K Buy
+136
New +$1.67K ﹤0.01% 1132
2019
Q2 		– Sell
-137
Closed -$2K – 1595
2019
Q1 		$2K Buy
137
+84
+158% +$1.04K ﹤0.01% 1144
2018
Q4 		$1K Sell
53
-8
-13% -$106 ﹤0.01% 1182
2018
Q3 		$1K Buy
61
+9
+17% +$126 ﹤0.01% 1233
2018
Q2 		$1K Sell
52
-16
-24% -$278 ﹤0.01% 1205
2018
Q1 		$1K Buy
+68
New +$1.26K ﹤0.01% 1150

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Parkside Financial Bank & Trust's CORT Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Corcept Therapeutics (CORT) stake by 30% in Q1 2026, buying an estimated $598 and bringing the position to 69 shares worth $2.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Parkside Financial Bank & Trust first reported a position in CORT in Q1 2018 and has held it in 32 quarters since. The position peaked at $9.7K in Q3 2023. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Parkside Financial Bank & Trust held 69 shares of Corcept Therapeutics worth $2.78K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 16 Corcept Therapeutics shares in Q1 2026, an estimated $598.
  • Corcept Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2004 holding.
  • Parkside Financial Bank & Trust first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 32 quarters since.
  • Parkside Financial Bank & Trust's Corcept Therapeutics position peaked at $9.7K in Q3 2023.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.